New cell therapy tested for Tough-to-Treat blood cancer
Disease control
Not yet recruiting
This is an early-stage study to test the safety and find the right dose of an experimental cell therapy called CT0991. It will involve up to 24 adults whose acute myeloid leukemia has come back or has not responded to previous treatments. The main goal is to see how well patients…
Phase: PHASE1 • Sponsor: MEI HENG • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC